TSX open
Loading marketsโ€ฆ

Advertisement

Stocks

What's Going On With Guardian Capital Group Ltd. Cl.A Nv (GCG-A.TO Stock Thursday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:GCG-A.TO

Get GCG-A alerts:

Photos provided by Pexels

Guardian Capital Group Ltd. Cl.A Nv remains steady amid significant corporate developments.

This week, Guardian Capital Group Ltd. Cl.A Nv (GCG-A.TO) has seen no change in its stock price, closing at C$67.99. The company is in the process of a take-private transaction led by Desjardins Global Asset Management Inc., which is poised to reshape its future.

Advertisement

Guardian Capital Group Ltd. Cl.A Nv (GCG-A.TO

GCG-A.TO

Full stock page โ†’

GCG-A.TO

Guardian Capital Group Ltd. Cl.A Nv (GCG-A.TO

Source:WealthAwesomeWealthAwesome
โ†‘ $26.71 (64.70%)
120 day period
$40.94$54.46$67.99Aug 14Dec 29Mar 24

Market cap

$1.67B

P/E

9.1x

Div. yield

2.30%

Div. / share

$1.56

52W high

$67.99

52W low

$37.21

1W change

+0.00%

Beta

0.94

Analyst Price Targets

Based on analyst covering GCG-A

๐Ÿ“‰

Wall Street analysts forecast GCG-A stock price to fall 19.1% over the next 12 months.

Consensus

Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$55.00

-19.1% Upside

Current Price

C$67.99

Last close

Compare analyst targets across the TSX & TSXV โ†’

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GCG-A's historical volatility

HistoricalForecast68%95%
C$64.84C$66.56C$68.28C$70.00C$71.72C$73.44TodayNov 13Jan 20Mar 24May 6Jun 19Aug 1

30-Day Vol

2.7%

Annualized

90-Day Vol

2.0%

Annualized

Trend (90d)

+4.3%

Annualized drift

90d Mean

C$69.04

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$68.34C$67.70 โ€“ C$68.98
60 trading daysC$68.69C$67.79 โ€“ C$69.60
90 trading daysC$69.04C$67.93 โ€“ C$70.16

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: With the completion of its acquisition by Desjardins expected soon, Guardian Capital's stock is stabilizing, presenting a moment of reflection for investors as they evaluate the implications of this transition.

Guardian Capital's stock remains stable at C$67.99 amidst acquisition developments.

The company's market cap stands at C$1.67 billion, supported by a solid profit margin of 48.2% and an impressive return on equity of 13.9%.

Bull case

The acquisition by Desjardins could provide Guardian with better resources and strategic direction. This may lead to improved operational efficiencies and new growth opportunities for the company.

Bear case

Analysts have a cautious outlook, with an average target of C$55.00 for the stock. This suggests that the market is wary of how the company will perform after the acquisition.

Price Action Overview

Advertisement

This week, Guardian Capital Group Ltd. Cl.A Nv (GCG-A.TO) has experienced no fluctuations, maintaining its closing price at C$67.99. Year-to-date, the stock has shown a modest increase of 0.95%. Despite the lack of movement in the stock price, the ongoing acquisition process is a significant factor influencing investor sentiment.

Corporate Developments

Recent headlines indicate that Guardian Capital Group has successfully completed the necessary steps for its acquisition by Desjardins Global Asset Management Inc. This transaction is expected to close on or about March 23, 2026, following the receipt of all regulatory approvals. The implications of this acquisition could be substantial, potentially leading to a re-evaluation of the company's strategic direction and operations.

Technical Picture

From a technical standpoint, Guardian Capital's stock is currently trading above its 50-day moving average of C$67.45 and significantly above its 200-day moving average of C$60.10, indicating a positive long-term trend. The stock has a beta of 0.94, suggesting it is slightly less volatile than the market. The 52-week range of C$37.21 to C$67.99 highlights the stock's considerable growth potential over the past year. However, the current trading volume of 17,461 shares is below the 20-day average of 45,420 shares, suggesting reduced trading activity.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile โ†’

โœ… Reviewed by Certified Financial Professionals

This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

๐Ÿ“Š Data AccuracyVerified sources
๐Ÿ‡จ๐Ÿ‡ฆ Canadian FocusLocal expertise
๐Ÿ” Fact-CheckedEditorial review

โš ๏ธ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 27, 2026
Last Updated: August 27, 2026
PARTNER SPOTLIGHT

Blue Cross Lifeยฎ Term Life Insurance

Affordable term life coverage in Canada โ€” get a free quote in seconds, no credit card required.

  • โœ“Coverage from $100,000 to $5 million, terms of 10โ€“30 years
  • โœ“10% off first-year premiums when couples apply together
  • โœ“Fully digital application โ€” many qualify without a medical exam

Sponsored links

Advertisement